Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Swedish Match in the acquisition of Gotlandssnus
Mandate

Vinge advises Swedish Match in the acquisition of Gotlandssnus

July 31, 2018 M&A

Founded in 2002, Gotlandssnus develops, produces, and sells both snus and nicotine-free products, with sales in Sweden, the US, Asia, and parts of Europe.

The company sells popular brands such as Jakobsson’s snus and Qvitt (nicotine and tobacco free pouches). Gotlandssnus produces approximately 4 million cans per year. The production facility and head office are located in Romakloster, Gotland. The current managing director and founder Henrik Jakobsson will remain as the managing director of Gotlandssnus and also as a minority shareholder of the company.
 
Vinge’s team consisted of partner Jonas Johansson and associate Karl Klackenberg.

Related

Vinge has advised EQT AB in connection with the refinancing of EQT’s EUR 1,500,000,000 sustainability-linked revolving credit facility

 The sustainability-linked credit facility has a tenor of 5 years with two 1-year extension options.
July 23, 2024

Vinge has advised Embracer Group in connection with a EUR 600 million multicurrency revolving facility agreement

Vinge has advised Embracer Group in connection with a EUR 600 million multicurrency revolving facility agreement entered into with BNP Paribas, Citibank Europe, DNB, JP Morgan, Nordea, SEB and Swedbank.
July 19, 2024

Vinge has advised SBB and Sveafastigheter in connection with an exchange offer

 Vinge has advised Samhällsbyggnadsbolaget i Norden AB (SBB) and Sveafastigheter AB in connection with an exchange offer directed to investors in SBB’s outstanding bonds, whereby investors exchanged senior and hybrid bonds in SBB for new senior bonds issued in Sveafastigheter AB. The existing bonds were partly issued under SBB’s EMTN programme, partly on a standalone basis. Following the transaction, the investors have been slotted in under Swedish bond terms on a standalone basis.
July 09, 2024